Vissum, Instituto Oftalmológico de Alicante

Quick facts

Phase 2 pipeline

• PRP autologous

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Vissum, Instituto Oftalmológico de Alicante portfolio CI brief
• Vissum, Instituto Oftalmológico de Alicante pipeline updates RSS

Related

• Sector hub: All tracked pharma companies